Newsletters

  • All
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
CARB-XR&D Insight

CARB-X funding round #1, SDRI 2017, & Antibiotic-tainted seafood

Dear All: Just in case you missed the 30 March annoucement, see at right a snapshot of the first 11 Powered …

Read More >
R&D Insight

Antimicrobial Effects of Antipyretics, a paper in AAC by Zimmerman & Curtis

Dear All: OK, I’ll say that I’m sending this around because the title was so intriguing and reminded me of the …

Read More >
R&D Insight

International Course on Antibiotics and Resistance ICARe, 11-19 Nov 2017

Dear All: FYI, see below an announcement of an 8-day intensive course in Paris in November 2017: “ICARe is designed …

Read More >
R&D Insight

IDSA’s Faces of Antimicrobial Resistance (FAOR) report

Dear All: This one appears to have been released on 7 Mar but it just crossed my desk today. In …

Read More >
Something Different

Useful AMR graphics: Poirel 2017 and Marston 2016

Dear All: There’s a very comprehensive review of the polymyxins by Poirel, Jayol, and Nordmann just out in Clin Micro …

Read More >
Government Action

European Parliament Resolution on Access to (and value of) Medicines

Dear All: The attached EU Parliament resolution on Access to Medicines was released today. Broadly, it calls for greater transparency in price …

Read More >
FDAMeetings

FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa

Dear All: FDA today hosted their eagerly awaited workshop on animal models in support of narrow-spectrum agents for A. baumannii (Abau) and P. …

Read More >
R&D InsightWHO

WHO 2017 Priority Pathogens List

Dear All: The new WHO priority pathogen list for R&D has been released! It’s entirely focused on bacteria both otherwise …

Read More >
FDAR&D Insight

Benefit-Risk analyses: Gassman et al. (NEJM) + FDA

Dear All: An article by Gassman, Nguyen, and Joffe in today’s NEJM entitled “FDA regulation of prescription drugs” caught my …

Read More >
Scroll to Top